GSA Capital Partners LLP Has $1.57 Million Stock Holdings in Centene Co. (NYSE:CNC)

GSA Capital Partners LLP grew its position in Centene Co. (NYSE:CNCFree Report) by 435.0% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 20,052 shares of the company’s stock after purchasing an additional 16,304 shares during the quarter. GSA Capital Partners LLP’s holdings in Centene were worth $1,574,000 as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. Turtle Creek Wealth Advisors LLC acquired a new position in shares of Centene during the fourth quarter valued at about $25,000. Rise Advisors LLC purchased a new position in Centene in the 1st quarter worth approximately $25,000. Riggs Asset Managment Co. Inc. purchased a new position in Centene in the 4th quarter worth approximately $32,000. Headinvest LLC purchased a new stake in shares of Centene in the 3rd quarter valued at $35,000. Finally, Neo Ivy Capital Management purchased a new stake in shares of Centene in the 4th quarter valued at $40,000. 93.63% of the stock is owned by institutional investors.

Analyst Ratings Changes

CNC has been the subject of a number of recent analyst reports. Wells Fargo & Company upped their price target on shares of Centene from $89.00 to $93.00 and gave the company an “overweight” rating in a report on Monday, April 15th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $90.00 price target on shares of Centene in a research note on Wednesday, June 12th. Baird R W upgraded shares of Centene to a “hold” rating in a research note on Thursday, May 30th. Barclays increased their price objective on shares of Centene from $101.00 to $104.00 and gave the company an “overweight” rating in a research report on Thursday, May 2nd. Finally, Oppenheimer reaffirmed an “outperform” rating and set a $110.00 price target on shares of Centene in a report on Friday, June 21st. Eight analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, Centene presently has an average rating of “Hold” and an average target price of $85.54.

View Our Latest Stock Analysis on Centene

Insiders Place Their Bets

In other news, President Kenneth J. Fasola sold 8,000 shares of the stock in a transaction on Monday, May 13th. The stock was sold at an average price of $77.62, for a total transaction of $620,960.00. Following the completion of the transaction, the president now directly owns 300,357 shares in the company, valued at approximately $23,313,710.34. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, Director Christopher J. Coughlin sold 878 shares of the firm’s stock in a transaction dated Tuesday, May 14th. The stock was sold at an average price of $76.75, for a total transaction of $67,386.50. Following the sale, the director now owns 25,504 shares of the company’s stock, valued at approximately $1,957,432. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, President Kenneth J. Fasola sold 8,000 shares of the firm’s stock in a transaction dated Monday, May 13th. The stock was sold at an average price of $77.62, for a total value of $620,960.00. Following the sale, the president now directly owns 300,357 shares in the company, valued at approximately $23,313,710.34. The disclosure for this sale can be found here. Corporate insiders own 0.29% of the company’s stock.

Centene Stock Performance

Centene stock traded up $0.13 during mid-day trading on Wednesday, hitting $65.87. The company had a trading volume of 398,336 shares, compared to its average volume of 3,334,403. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.66. Centene Co. has a 12-month low of $60.83 and a 12-month high of $81.42. The company’s fifty day moving average is $71.37 and its 200-day moving average is $74.47. The company has a market capitalization of $35.15 billion, a price-to-earnings ratio of 13.07, a P/E/G ratio of 0.85 and a beta of 0.50.

Centene (NYSE:CNCGet Free Report) last announced its earnings results on Friday, April 26th. The company reported $2.26 earnings per share for the quarter, topping the consensus estimate of $2.09 by $0.17. Centene had a return on equity of 14.19% and a net margin of 1.76%. The business had revenue of $40.41 billion during the quarter, compared to the consensus estimate of $36.43 billion. During the same period in the prior year, the company posted $2.11 EPS. The business’s quarterly revenue was up 3.9% on a year-over-year basis. Equities research analysts predict that Centene Co. will post 6.82 EPS for the current year.

Centene Company Profile

(Free Report)

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support.

See Also

Institutional Ownership by Quarter for Centene (NYSE:CNC)

Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.